ALDX - Aldeyra Therapeutics, Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$9.67
DETAILS
HIGH:
$12.00
LOW:
$7.00
MEDIAN:
$10.00
CONSENSUS:
$9.67
UPSIDE:
523.87%
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | |||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.1 | 0.0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.1) | (0.0) | (0.0) | (0.0) | 0 | 0 | 0 | 0 |
| Operating Expenses | |||||||||||||||
| R&D Expenses | 25.7 | 48.2 | 29.5 | 47.3 | 44.9 | 24.7 | 44.4 | 29.8 | 16.3 | 13.2 | 7.6 | 3.7 | 1.5 | 0.5 | 1.4 |
| SG&A Expenses | 9.6 | 11.9 | 13.3 | 15.4 | 11.3 | 10.0 | 12.2 | 9.9 | 6.2 | 5.5 | 4.4 | 3.6 | 2.1 | 0.6 | 0.7 |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses | 35.3 | 60.1 | 42.8 | 62.7 | 56.2 | 34.7 | 56.5 | 39.7 | 22.5 | 18.7 | 12.0 | 7.3 | 3.7 | 1.1 | 2.1 |
| Operating Income | |||||||||||||||
| Operating Income | (35.3) | (60.1) | (42.8) | (62.7) | (56.2) | (36.4) | (63.1) | (39.7) | (22.5) | (18.7) | (12.0) | (7.3) | (3.7) | (1.1) | (2.1) |
| Interest Expense | 1.9 | 1.9 | 2.1 | 1.7 | 1.7 | 1.9 | 0.6 | 0.1 | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 | 0.3 | 0.3 |
| Interest Income | 3.3 | 6.2 | 7.3 | 2.3 | 0.2 | 0.3 | 1.5 | 1.0 | 0.3 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Profitability | |||||||||||||||
| EBITDA | (31.7) | (53.7) | (35.2) | (60.1) | (55.8) | (34.3) | (61.4) | (38.7) | (22.2) | (18.6) | (12.0) | (4.9) | 13.2 | (22.7) | (2.1) |
| EBIT | (31.9) | (53.9) | (35.5) | (60.3) | (56.0) | 0 | (61.5) | (38.7) | (22.2) | (18.6) | (12.0) | (4.9) | 13.2 | (22.7) | (2.1) |
| Income Before Tax | (33.8) | (55.9) | (37.5) | (62.0) | (57.8) | (38.0) | (62.1) | (38.9) | (22.3) | (18.7) | (12.1) | (5.2) | 13.1 | (23.1) | (2.4) |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | (0.5) | (1.3) | 0 | 0.2 | 0.1 | (0.0) | 0 | 0 | 0 | 0 |
| Net Income | (33.8) | (55.9) | (37.5) | (62.0) | (57.8) | (37.6) | (60.8) | (38.9) | (22.3) | (18.7) | (12.1) | (5.2) | 13.1 | (23.1) | (2.4) |
| Per Share Data | |||||||||||||||
| EPS (Basic) | -0.56 | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 | -1.40 | -1.36 | 39.90 | -146.63 | -7.26 |
| EPS (Diluted) | -0.56 | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 | -1.40 | -1.35 | 2.72 | -19.22 | -0.50 |
| Shares Outstanding | 60.1 | 59.5 | 58.9 | 58.4 | 54.0 | 34.0 | 27.1 | 21.7 | 15.9 | 11.4 | 8.6 | 3.8 | 4.0 | 0.2 | 0.3 |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Assets | ||||||||||
| Cash & Cash Equivalents | 70.0 | 54.5 | 142.8 | 144.4 | 229.8 | 77.9 | 44.4 | 47.4 | 20.0 | 12.0 |
| Short-Term Investments | 0 | 46.6 | 0 | 29.9 | 0 | 0 | 28.9 | 46.2 | 22.9 | 12.9 |
| Net Receivables | 0 | 0 | 0 | 3.2 | 0.0 | 0 | 0 | 0 | 0 | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 1.3 | 2.5 | 4.6 | 3.0 | 2.5 | 4.8 | 1.4 | 0 | 0 | 0 |
| Total Current Assets | 71.8 | 104.1 | 147.8 | 181.0 | 232.8 | 83.1 | 75.2 | 94.8 | 44.0 | 25.1 |
| Non-Current Assets | ||||||||||
| Property, Plant & Equipment | 0.3 | 0.3 | 0.5 | 0.3 | 0.4 | 0.3 | 0.3 | 0.2 | 0.0 | 0.1 |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0.3 | 0 | 0 | 0 | 0 | 0 | 0.1 | 0.2 | 0 |
| Total Non-Current Assets | 0.3 | 0.5 | 0.5 | 0.3 | 0.4 | 0.3 | 0.3 | 0.3 | 0.2 | 0.1 |
| Total Assets | 72.1 | 104.6 | 148.3 | 181.3 | 233.1 | 83.4 | 75.5 | 95.1 | 44.2 | 25.2 |
| Current Liabilities | ||||||||||
| Account Payables | 0.2 | 0.2 | 1.3 | 0.1 | 1.0 | 0.4 | 0.8 | 3.1 | 1.0 | 0.3 |
| Short-Term Debt | 15.2 | 0.0 | 15.1 | 0.9 | 0 | 3.7 | 0 | 0 | 0.1 | 0.1 |
| Deferred Revenue | 6 | 6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.3 | 4.3 | 3.1 | 3.8 | 1.5 | 1.3 | 1.5 | 1.2 | 0.8 | 1.0 |
| Total Current Liabilities | 27.8 | 18.6 | 22.3 | 15.4 | 11.8 | 12.4 | 12.9 | 8.5 | 3.4 | 2.3 |
| Non-Current Liabilities | ||||||||||
| Long-Term Debt | 0 | 15 | 0 | 14.9 | 15.5 | 11.4 | 14.5 | 0 | 1.2 | 1.2 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Liabilities | 0 | 15 | 6.3 | 14.9 | 15.6 | 11.4 | 14.5 | 0 | 1.2 | 1.2 |
| Total Liabilities | 27.8 | 33.6 | 28.5 | 30.3 | 27.4 | 23.8 | 27.4 | 8.5 | 4.6 | 3.5 |
| Stockholders' Equity | ||||||||||
| Common Stock | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Retained Earnings | (484.0) | (450.1) | (394.3) | (356.7) | (294.7) | (236.9) | (199.4) | (138.5) | (99.6) | (77.3) |
| Accumulated Other Comprehensive Income | 0 | 0.0 | 0 | (0.1) | 0 | 0 | 0.0 | (0.0) | (0.0) | 0.0 |
| Total Stockholders' Equity | 44.3 | 71.0 | 119.8 | 151.0 | 205.7 | 59.5 | 48.1 | 86.6 | 39.6 | 21.6 |
| Total Liabilities & Equity | 72.1 | 104.6 | 148.3 | 181.3 | 233.1 | 83.4 | 75.5 | 95.1 | 44.2 | 25.2 |
| Debt Metrics | ||||||||||
| Total Debt | 15.5 | 15.3 | 15.7 | 16.1 | 15.9 | 15.3 | 14.8 | 0 | 1.3 | 1.3 |
| Net Debt | (54.5) | (39.2) | (127.2) | (128.3) | (213.9) | (62.5) | (29.7) | (47.4) | (18.7) | (10.7) |
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||||
| Net Income | (33,846,661) | (55.9) | (37.5) | (62.0) | (57.8) | (37.6) | (60.8) | (38.9) | (22.3) | (18.7) |
| Depreciation & Amortization | (897,557) | 0.2 | 0.3 | 0.3 | 0.3 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 |
| Stock-Based Compensation | 6,091,413 | 8.0 | 5.8 | 8.3 | 7.1 | 7.1 | 8.1 | 4.1 | 2.7 | 2.8 |
| Change in Working Capital | (5.2) | 5.9 | 0.9 | (3.4) | 7.4 | (8.8) | 2.7 | 5.0 | 0.2 | 0.5 |
| Other Non-Cash Items | (4,692,871.8) | (1.5) | 0.3 | 0.3 | 0.4 | 2.2 | 6.2 | 0.1 | 0.0 | 0.0 |
| Operating Cash Flow | (33,345,682) | (43.2) | (30.3) | (56.6) | (42.6) | (37.5) | (45.0) | (29.9) | (19.2) | (15.1) |
| Investing Activities | ||||||||||
| Capital Expenditure | 0 | 0 | 0 | (0.0) | (0.0) | 0 | (0.0) | (0.3) | (0.0) | (0.0) |
| Acquisitions | 0 | 0 | 0 | 0.0 | 0 | 0 | 0.6 | 262,966 | 24,759 | 0.0 |
| Purchases of Investments | (40,263,712) | (96.9) | 0 | (92.9) | 0 | (5.8) | (57.8) | (59.7) | (35.1) | (16.0) |
| Sales/Maturities of Investments | 88,000,000 | 52 | 30 | 63 | 0 | 34.8 | 75.6 | 36.7 | 24.9 | 15.8 |
| Other Investing Activities | 0 | 0 | 0 | (0.0) | 0 | 0 | 0 | (262,966) | (24,759) | (0.0) |
| Investing Cash Flow | 47,736,288 | (44.9) | 30 | (30.0) | (0.0) | 29.0 | 18.5 | (23.3) | (10.2) | (0.2) |
| Financing Activities | ||||||||||
| Net Debt Issuance | 0 | (0.3) | (1.0) | 0 | 0 | 0 | 14.4 | 0 | 0 | 0 |
| Stock Repurchased | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 1,123,554.9 | 0 | (0.5) | 0 | 4.7 | 1.2 | 1.2 | (1.4) | (0.2) | 0 |
| Financing Cash Flow | 1,123,556 | (0.2) | (1.3) | 1.2 | 194.5 | 41.9 | 23.6 | 80.5 | 37.4 | 12.7 |
| Cash Position | ||||||||||
| Net Change in Cash | 15,514,162 | (88.3) | (1.6) | (85.4) | 151.9 | 33.4 | (2.9) | 27.3 | 8.0 | (2.6) |
| Cash at Beginning | 54,527,092 | 142.8 | 144.4 | 229.8 | 77.9 | 44.4 | 47.4 | 20.0 | 12.0 | 14.6 |
| Cash at End | 70,041,254 | 54.5 | 142.8 | 144.4 | 229.8 | 77.9 | 44.4 | 47.4 | 20.0 | 12.0 |
| Free Cash Flow | (33,345,682) | (43.2) | (30.3) | (56.7) | (42.6) | (37.5) | (45.0) | (30.1) | (19.2) | (15.2) |
| Key Metrics | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||||||
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | 0 | 0 | 0 | 0 | 0 | (0.1) | (0.1) | (0.0) | (0.0) | (0.0) | 0 | 0 | 0 | 0 |
| Operating Income | (35.3) | (60.1) | (42.8) | (62.7) | (56.2) | (36.4) | (63.1) | (39.7) | (22.5) | (18.7) | (12.0) | (7.3) | (3.7) | (1.1) | (2.1) |
| Net Income | (33.8) | (55.9) | (37.5) | (62.0) | (57.8) | (37.6) | (60.8) | (38.9) | (22.3) | (18.7) | (12.1) | (5.2) | 13.1 | (23.1) | (2.4) |
| EPS (Diluted) | -0.56 | -0.94 | -0.64 | -1.06 | -1.07 | -1.11 | -2.24 | -1.79 | -1.40 | -1.65 | -1.40 | -1.35 | 2.72 | -19.22 | -0.50 |
| Balance Sheet | |||||||||||||||
| Cash & Equivalents | 70.0 | 54.5 | 142.8 | 144.4 | 229.8 | 77.9 | 44.4 | 47.4 | 20.0 | 12.0 | |||||
| Total Assets | 72.1 | 104.6 | 148.3 | 181.3 | 233.1 | 83.4 | 75.5 | 95.1 | 44.2 | 25.2 | |||||
| Total Debt | 15.5 | 15.3 | 15.7 | 16.1 | 15.9 | 15.3 | 14.8 | 0 | 1.3 | 1.3 | |||||
| Stockholders' Equity | 44.3 | 71.0 | 119.8 | 151.0 | 205.7 | 59.5 | 48.1 | 86.6 | 39.6 | 21.6 | |||||
| Cash Flow | |||||||||||||||
| Operating Cash Flow | (33,345,682) | (43.2) | (30.3) | (56.6) | (42.6) | (37.5) | (45.0) | (29.9) | (19.2) | (15.1) | |||||
| Capital Expenditure | 0 | 0 | 0 | (0.0) | (0.0) | 0 | (0.0) | (0.3) | (0.0) | (0.0) | |||||
| Free Cash Flow | (33,345,682) | (43.2) | (30.3) | (56.7) | (42.6) | (37.5) | (45.0) | (30.1) | (19.2) | (15.2) | |||||